A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies

NCT01798745 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped study not required for development

Conditions

Heart Failure

Interventions

DRUG: JNJ-54452840
OTHER: Placebo

Sponsor

Janssen Research & Development, LLC